Daniel Boffa, MD

• Andre Levchenko
• Andrew Dhanasopon
• Anne Chiang
• Benjamin L. Judson
• Benjamin Resio
• Cary Gross
• Danielle Heller
• Dhanpat Jain
• Dirk Johnson
• Elena Ratner
• Frank Detterbeck
• Harriet Kluger
• Harry Aslanian
• James Clune
• Jason L Schwartz
• Jeph Herrin
• John Morton
• Jun Lu
• Justin D. Blasberg
• Kelly Olino
• Kerin Adelson
• Kevin Billingsley
• Kimberly Davis
• Laura Niklason
• Loren Laine
• Lynn Tanoue
• Maria Ciarleglio
• Marianna Papageorge
• Mario Sznol
• Matthew Pichert
• Maureen Canavan
• Maxwell Laurans
• Michael Ancuta
• Michael S. Leapman
• Michelle Salazar
• Naftali Kaminski
• Nita Ahuja
• Peter Steven Yoo
• Ronald Salem
• Roy H. Decker
• Sajid A Khan
• Sarah Goldberg
• Sarah Weiss
• Scott Gettinger
• Stephan Ariyan
• Taylor Adams
• Trevor Banack
• Vincent Mase
• Xiao Xu
• Yifan Yuan
• Yuval Kluger
• Zuoheng Anita Wang

Medical Oncology

• ASO Author Reflections: Complex Cancer Surgery Mortality After 30 Days: An Opportunity for Improvement.Resio BJ, Boffa DJ. ASO Author Reflections: Complex Cancer Surgery Mortality After 30 Days: An Opportunity for Improvement. Annals Of Surgical Oncology 2021, 28:1287-1288.
• Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer Surgery.Resio BJ, Gonsalves L, Canavan M, Mueller L, Phillips C, Sathe T, Swett K, Boffa DJ. Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer Surgery. Annals Of Surgical Oncology 2021, 28:1278-1286.
• COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network.Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P, Clark JM, Cooke D, David E, Facktor M, Farjah F, Grogan E, Isbell J, Jones DR, Kidane B, Kim AW, Keshavjee S, Krantz S, Lui N, Martin L, Meguid RA, Meyerson SL, Mullett T, Nelson H, Odell DD, Phillips JD, Puri V, Rusch V, Shulman L, Varghese TK, Wakeam E, Wood DE. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. The Journal Of Thoracic And Cardiovascular Surgery 2020, 160:601-605.
• Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals.Boffa DJ, Mallin K, Herrin J, Resio B, Salazar MC, Palis B, Facktor M, McCabe R, Nelson H, Shulman LN. Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Network Open 2020, 3:e203942.
• Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer.Leapman MS, Presley CJ, Zhu W, Soulos PR, Adelson KB, Miksad RA, Boffa DJ, Gross CP. Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer. JAMA Network Open 2020, 3:e207205.
• Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer.Resio BJ, Canavan M, Mase V, Dhanasopon AP, Blasberg JD, Boffa DJ. Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer. The Annals Of Thoracic Surgery 2020, 110:390-397.
• Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway.Boffa DJ, Judson BL, Billingsley KG, Galeta D, Fontanez P, Odermatt C, Lindner K, Mitchell MR, Henderson CM, Carafeno T, Pinto J, Wagner J, Ancuta M, Beley P, Turner AL, Banack T, Laurans MS, Johnson DC, Yoo P, Morton JM, Zurich H, Davis K, Ahuja N. Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway. The Annals Of Thoracic Surgery 2020, 110:718-724.
• Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer.Onaitis MW, Furnary AP, Kosinski AS, Feng L, Boffa D, Tong BC, Cowper P, Jacobs JP, Wright CD, Habib R, Putnam JB, Fernandez FG. Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer. The Annals Of Thoracic Surgery 2020, 110:1882-1891.
• Surgeon's Perspective to Local Therapy in Oligometastatic Cancer.Boffa DJ. Surgeon's Perspective to Local Therapy in Oligometastatic Cancer. Cancer Journal (Sudbury, Mass.) 2020, 26:149-155.
• Variations in Surgical Safety According to Affiliation Status With a Top-Ranked Cancer Hospital.Resio BJ, Hoag JR, Chiu AS, Monsalve A, Sathe T, Xu X, Boffa DJ. Variations in Surgical Safety According to Affiliation Status With a Top-Ranked Cancer Hospital. JAMA Oncology 2019, 5:1359-1362.
• Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.Uhlig J, Case MD, Blasberg JD, Boffa DJ, Chiang A, Gettinger SN, Kim HS. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer. JAMA Network Open 2019, 2:e199702.
• Regionalization of esophagectomy: where are we now?Clark JM, Boffa DJ, Meguid RA, Brown LM, Cooke DT. Regionalization of esophagectomy: where are we now? Journal Of Thoracic Disease 2019, 11:S1633-S1642.
• The Society of Thoracic Surgeons General Thoracic Surgery Database: 2019 Update on Research.Crabtree TD, Boffa DJ, Lobdell KW, Habib RH, Gaissert HA. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2019 Update on Research. The Annals Of Thoracic Surgery 2019, 108:1293-1298.
• Single-cell connectomic analysis of adult mammalian lungs.Raredon MSB, Adams TS, Suhail Y, Schupp JC, Poli S, Neumark N, Leiby KL, Greaney AM, Yuan Y, Horien C, Linderman G, Engler AJ, Boffa DJ, Kluger Y, Rosas IO, Levchenko A, Kaminski N, Niklason LE. Single-cell connectomic analysis of adult mammalian lungs. Science Advances 2019, 5:eaaw3851.
• Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma.Kurbatov V, Balayev A, Saffarzadeh A, Heller DR, Boffa DJ, Blasberg JD, Lu J, Khan SA. Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma. The Annals Of Thoracic Surgery 2020, 109:343-349.
• Sternotomy for aortic dissection with substernal pull through: The importance of surgical history.Pichert M, Mori M, Boffa DJ, Mangi AA. Sternotomy for aortic dissection with substernal pull through: The importance of surgical history. The Journal Of Thoracic And Cardiovascular Surgery 2020, 159:e325-e326.
• Commentary: The majority of minorities.Salazar MC, Boffa DJ. Commentary: The majority of minorities. The Journal Of Thoracic And Cardiovascular Surgery 2020, 160:272-273.
• Commentary: How surprising.Boffa DJ, Salazar M. Commentary: How surprising. The Journal Of Thoracic And Cardiovascular Surgery 2020, 159:2483-2484.
• Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database.Sathe TS, Resio BJ, Hoag JR, Monsalve AF, Pathak R, Blasberg JD, Mase V, Dhanasopon A, Boffa DJ. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database. The Annals Of Thoracic Surgery 2020, 109:1656-1662.
• Corrigendum to 'Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy' [Surgery 164/6 (2018) 1294-1299].Jean RA, Chiu AS, Boffa DJ, Detterbeck FC, Kim AW, Blasberg JD. Corrigendum to 'Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy' [Surgery 164/6 (2018) 1294-1299]. Surgery 2019, 165:1058.
• Variable impact of prior cancer history on the survival of lung cancer patients.Monsalve AF, Hoag JR, Resio BJ, Chiu AS, Brown LB, Detterbeck FC, Blasberg JD, Boffa DJ. Variable impact of prior cancer history on the survival of lung cancer patients. Lung Cancer (Amsterdam, Netherlands) 2019, 127:130-137.
• What's Lost in What's Missing: A Thoughtful Approach to Missing Data in the National Cancer Database.Boffa DJ. What's Lost in What's Missing: A Thoughtful Approach to Missing Data in the National Cancer Database. Annals Of Surgical Oncology 2019, 26:709-710.
• Lack of correlation between short- and long-term performance after lung cancer surgery.Fernandez FG, Kosinski AS, Tong BC, Furnary AP, Feng L, Onaitis M, Boffa D, Wright CD, Cowper P, Jacobs JP, Habib RH, Putnam JB. Lack of correlation between short- and long-term performance after lung cancer surgery. The Journal Of Thoracic And Cardiovascular Surgery 2019, 157:1633-1643.e3.
• Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer Surgery.Hoag JR, Resio BJ, Monsalve AF, Chiu AS, Brown LB, Herrin J, Blasberg JD, Kim AW, Boffa DJ. Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer Surgery. JAMA Network Open 2019, 2:e191912.
• Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancer.Resio BJ, Hoag J, Chiu A, Monsalve A, Dhanasopon AP, Boffa DJ, Blasberg JD. Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancer. Journal Of Thoracic Disease 2019, 11:811-818.
• Endoscopic versus Open Vein-Graft Harvesting for CABG.Saffarzadeh A, Hoag JR, Boffa DJ. Endoscopic versus Open Vein-Graft Harvesting for CABG. The New England Journal Of Medicine 2019, 380:e43.
• Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.Klemen ND, Wang M, Feingold PL, Cooper K, Pavri SN, Han D, Detterbeck FC, Boffa DJ, Khan SA, Olino K, Clune J, Ariyan S, Salem RR, Weiss SA, Kluger HM, Sznol M, Cha C. Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma. Journal For Immunotherapy Of Cancer 2019, 7:196.
• Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall.Gao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Clinical Lung Cancer 2017, 18:169-177.e4.
• The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies.Jawitz OK, Wang Z, Boffa DJ, Detterbeck FC, Blasberg JD, Kim AW. The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies. European Journal Of Cardio-thoracic Surgery : Official Journal Of The European Association For Cardio-thoracic Surgery 2017, 51:169-174.
• Using the National Cancer Database for Outcomes Research: A Review.Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DP. Using the National Cancer Database for Outcomes Research: A Review. JAMA Oncology 2017, 3:1722-1728.
• Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.Thomas DC, Arnold BN, Rosen JE, Salazar MC, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery. Lung Cancer (Amsterdam, Netherlands) 2017, 103:75-81.
• The Eighth Edition Lung Cancer Stage Classification.Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. Chest 2017, 151:193-203.
• Effectiveness of local therapy for stage I non-small-cell lung cancer in nonagenarians.Arnold BN, Thomas DC, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. Effectiveness of local therapy for stage I non-small-cell lung cancer in nonagenarians. Surgery 2017, 162:640-651.
• Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery.Detterbeck FC, Zurich HB, Agarwal R, Blasberg JD, Boffa DJ, Delrossi EP, Finan ME, Hindinger KK, Kim AW, Pierson M. Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery. Connecticut Medicine 2017, 81:5-12.
• Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction.Vyas M, Celli R, Singh M, Patel N, Aslanian HR, Boffa D, Deng Y, Ciarleglio MM, Laine L, Jain D. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction. Human Pathology 2020, 105:67-73.
• Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.Pathak R, Goldberg SB, Canavan M, Herrin J, Hoag JR, Salazar MC, Papageorge M, Ermer T, Boffa DJ. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features. JAMA Oncology 2020, 6:1741-1750.
• Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act.Salazar MC, Canavan ME, Walters SL, Herrin J, Schwartz JL, Leapman M, Boffa DJ. Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act. JAMA Network Open 2020, 3:e2017544.
• Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic.Boffa DJ, Judson BL, Billingsley KG, Del Rossi E, Hindinger K, Walters S, Ermer T, Ratner E, Mitchell MR, Laurans MS, Johnson DC, Yoo PS, Morton JM, Zurich HB, Davis K, Ahuja N. Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic. Annals Of Surgery 2020, 272:e316-e320.
• Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer Surgery.Papageorge MV, Resio BJ, Monsalve AF, Canavan M, Pathak R, Mase VJ, Dhanasopon AP, Hoag JR, Blasberg JD, Boffa DJ. Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer Surgery. JNCI Cancer Spectrum 2020, 4:pkaa059.
• A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors.Walters SL, Canavan ME, Salazar MC, Resio BJ, Blasberg JD, Mase V, Boffa DJ. A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors. The Annals Of Thoracic Surgery 2020.
• Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data.Medbery RL, Fernandez FG, Kosinski AS, Tong BC, Furnary AP, Feng L, Onaitis M, Boffa D, Wright CD, Cowper P, Jacobs JP, Putnam JB, Habib RH. Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data. The Annals Of Thoracic Surgery 2021, 111:1781-1790.
• Commentary: Go big or stay home?Chilakamarry S, Boffa DJ. Commentary: Go big or stay home? The Journal Of Thoracic And Cardiovascular Surgery 2021, 161:1711-1712.
• Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study.Pathak R, Canavan ME, Walters S, Salazar MC, Boffa DJ. Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study. Journal Of Thoracic Disease 2021, 13:140-148.
• Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer-Reply.Pathak R, Boffa DJ. Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer-Reply. JAMA Oncology 2021.
• Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules.Li AX, Flores K, Canavan ME, Boffa DJ, Blasberg JD. Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules. The Annals Of Thoracic Surgery 2021.
• Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation.Bryan DS, Ferguson MK, Antonoff MB, Backhus LM, Birdas TJ, Blackmon SH, Boffa DJ, Chang AC, Chmielewski GW, Cooke DT, Donington JS, Gaissert HA, Hagen JA, Hofstetter WL, Kent MS, Kim KW, Krantz SB, Lin J, Martin LW, Meyerson SL, Mitchell JD, Molena D, Odell DD, Onaitis MW, Puri V, Putnam JB, Seder CW, Shrager JB, Soukiasian HJ, Stiles BM, Tong BC, Veeramachaneni NK. Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. The Annals Of Thoracic Surgery 2020.
• Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.Goodman KA, Ou FS, Hall NC, Bekaii-Saab T, Fruth B, Twohy E, Meyers MO, Boffa DJ, Mitchell K, Frankel WL, Niedzwiecki D, Noonan A, Janjigian YY, Thurmes PJ, Venook AP, Meyerhardt JA, O'Reilly EM, Ilson DH. Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2021, JCO2003611.